Tetra Bio-Pharma subsidiary Agro-Tek has signed an exclusive supply and distribution agreement with Engen Medical Corporation to distribute Engen’s Munchies B Gone gum in Canada.
Agro-Tek will have exclusive sales and distribution rights for the product in Canada for five years, under the agreement.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
US-based Engen Medical Corporation owns global patent and intellectual property rights to a number of chewing gum products.
Canadian biopharmaceutical company ProMetic Life Sciences has raised C$21.05m ($16.13m) through the private placement of 4.4 million shares upon exercise of warrants by California Capital Equity.
The placement was priced at C$0.47 ($0.36) a share.
UK-based biotechnology company Nemaura Pharma has announced that it will raise £5m ($6.24m) in equity financing from private investors.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe company intends to use the funds to advance its Micro-Patch solid dose micro-needle system for a harmonic biologic, while part of them will also help accelerate its clinical programmes to prepare the drug-device combination for the market.
Canadian immunotherapy company Medicenna Therapeutics has announced that it intends to raise C$3.6m ($2.76m) in gross proceeds through a private placement of 1.8 million shares of its common stock in order to fund its non-clinical and clinical programmes, as well as meet working capital and general corporate needs.
The shares are priced at C$2 ($1.5) each.
